Biomarkers of phenotype, prognosis and response to therapy in pancreatic cancer. [ 2009 - 2013 ]

Research Grant

Researchers: Dr David Chang (Principal investigator)

Brief description Pancreatic cancer (PC) is the 4th leading cause of cancer deaths in our society. This research is aimed at the discovery of novel biomarkers with the ability to forecast prognosis and response to treatments in patients with PC. Ultimately, this will lead to the “individualisation” of the treatment for each patient, so that the most appropriate therapy could be given to an individual patient. This would significantly improve the overall survival and the quality of life for patients.

Funding Amount $AUD 105,845.98

Funding Scheme NHMRC Postgraduate Scholarships

Notes Medical Postgraduate Scholarship